Navigation Links
Diabetes Conversation Map(TM) Education Tools Celebrate One-Year Anniversary
Date:10/21/2009

, which provide a dynamic learning experience for people living with diabetes, were first introduced in Europe last year, then in Latin America and Asia throughout 2008 and 2009. With more than 16,000 educational kits already distributed since launch, there is an extensive network of leadership and support partners within healthcare and government organizations around the world using and supporting the tools. In addition, more than 100 credentialed healthcare professionals, representing 68 countries and referred to as "Expert Trainers," have been trained not only on how to use the tools, but also on how to train other locally-based diabetes educators to conduct Conversation Map(TM) education sessions. As a result, these Expert Trainers have spurred an educational movement for thousands of people living with diabetes.

Currently, 285 million people live with diabetes worldwide and the number is projected to increase dramatically within the next 20 years.(1)( )Unlike other diseases, people with diabetes are responsible for 95 percent of their own care. Yet, many are faced with managing this disease - including making complex daily medical decisions - without proper education regarding their diabetes.(2)

"As part of our Global Education Programme to spread the word about diabetes education and prevention, IDF is working to identify and fill gaps in the provision of diabetes education worldwide," said Helen McGuire, global education manager, International Diabetes Federation. "We are pleased that educational instruments such as the Map tools are available to help prepare people with diabetes to make informed decisions and behavioral changes and, ultimately, better equip them to effectively manage their diabetes."

Designed for groups of three to 10, the Conversation Map(TM) education tools use the power of small group dialogue and collaborative learning to improve personal health management and enhance interactions between
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Societys Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)
2. New Data Showed Type 2 Diabetes Patients Experienced Greater Blood Sugar Reductions when Treated with ACTOplus met(R) (pioglitazone HCl and metformin HCl) as Initial Therapy Compared to Either Component Alone
3. Eurotech Unveils New Diabetes Care Management Solution
4. CSC Announces Billing Contract with Denver Endocrinology Diabetes and Metabolism
5. Data on VIVUS Qnexa to be Featured at European Association for the Study of Diabetes Annual Meeting
6. InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
7. Lexicon Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of LX4211 in Patients With Type 2 Diabetes
8. Exsulin Corporation Announces Next Phase II Trial of Novel Islet Regeneration Treatment in Type 1 Diabetes
9. Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOS(R) (pioglitazone HCl) for the Treatment of Type 2 Diabetes
10. Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes
11. WaveSense Diabetes Products Safe from Maltose Inaccuracy Risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... -- CVS Caremark Corporation (NYSE: CVS ) will ... 2014, at 8:30 a.m. (EDT) with analysts and investors ... An audio webcast of the conference call will ... the CVS Caremark website for all interested parties.  To ... will be archived and available on the web site ...
(Date:7/25/2014)... July 25, 2014  Acsis Inc., the market ... serialization solutions, has recently posted an article, ... current and future needs for companies, extended supply ... supply chain model no longer work today.  The ... the growth of mobile technology, machine to machine ...
(Date:7/25/2014)... Research and Markets has announced ... Market 2014-2018" report to their offering. ... Diagnostic Device An ophthalmic diagnostic device ... or deficiency in the human visual pathway. Ophthalmic devices ... presbyopia, cataracts, glaucoma, retinal disorders, conjunctivitis, and dry eyes. ...
Breaking Medicine Technology:Acsis Addresses Questions on the Modern Supply Chain 2Global Ophthalmic Diagnostic Devices Market 2014-2018: Key Vendors are Alcon, Carl Zeiss, Haag-Streit and Topcon 2
... 2011 Thoratec Corporation (Nasdaq: THOR ), a ... support and restore failing hearts, today announced that it will ... 2011 on Tuesday, November 1. The company will ... operating activities, open to all interested parties, at 1:30 p.m., ...
... 2011 NxStage Medical, Inc. (Nasdaq: ... products, today announced it ranked 141 on Deloitte,s Technology ... media, telecommunications, life sciences and clean technology companies in ... year revenue growth during the period from 2006–2010. NxStage ...
Cached Medicine Technology:Thoratec Schedules Third Quarter Conference Call, Webcast 2NxStage® Ranked Number 141 on the Fastest Growing Company in North America on Deloitte's 2011 Technology Fast 500™ 2NxStage® Ranked Number 141 on the Fastest Growing Company in North America on Deloitte's 2011 Technology Fast 500™ 3
(Date:7/25/2014)... Unlike children, the vast majority of adults finish all of ... to a new study. This is true for ... researchers from Cornell University revealed. They noted their findings ... eating habits make better choices. "If you put it ... Wansink, director of the Cornell Food and Brand Lab, ...
(Date:7/25/2014)... genes are switched on or off plays a key ... metabolism, UT Southwestern Medical Center researchers have found., The ... obesity and diabetes, since the transcription factor involved ... influence the body,s sensitivity to insulin and leptin signaling. ... regulation of food intake and sugar disposal, and obesity ...
(Date:7/25/2014)... July 25, 2014 The American Brain ... volunteer network “ABTA CommYOUnity™” during its annual patient and ... time for the brain tumor community as we – ... and caregiver support services and funding brain tumor research ... passionate about brain tumor awareness and getting our materials ...
(Date:7/25/2014)... Progress in understanding the molecular genetics of ... promising brain tumor treatments, according to Patrick Wen, MD, ... Center for Neuro-Oncology, Dana-Farber Cancer Institute. , At the ... Conference in Chicago, July 25-26, Dr. Wen will moderate ... impacting the development of new treatments and advancing strategies ...
(Date:7/25/2014)... San Jose, CA (PRWEB) July 25, 2014 ... MaaS360 WorkPlace Partner Program . Splashtop Business and ... MaaS360 Market, and will leverage the MaaS360 WorkPlace ... corporate data. , Splashtop Business and Splashtop Enterprise offer ... using any device. High performance, ease of ...
Breaking Medicine News(10 mins):Health News:Most Adults Are Members of 'Clean Plate Club' 2Health News:Manipulating key protein in the brain holds potential against obesity and diabetes 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 2Health News:American Brain Tumor Association Unveils Brand Identity for Newly Launched Volunteer Network 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 2Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 4Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 2Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 3Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 4
... of Hodgkin lymphoma, a common form of cancer of ... white blood cells (B cells), but have lost a ... The phenotype and the characteristics of Hodgkin lymphoma cells ... (Max Delbrck Center for Molecular Medicine, MDC, Berlin-Buch and ...
... Study finds 1 in 4 terminally ill not getting ... (HealthDay News) -- Oregon,s physician-assisted suicide law may not ... with clinical depression, a new study says. , The ... in 1997, and there,s been intense debate about the ...
... understand whether they may benefit from more,intensive screening, monitoring ... deCODE genetics,(Nasdaq: DCGN ) today announced the ... of the common forms of breast cancer. For the ... with her physician,about a genetic test to better understand ...
... Nominations are now being,accepted for The 2009 ... scientists in basic or clinical research who have ... Nominations will be accepted online at http://www.pauljanssenaward.com ... independent Selection,Committee. The winner(s) will be announced in ...
... TransForce(R)2 Arch Developer ... ... global manufacturer of orthodontic products, laboratory services,and continuing education programs, announced ... their new and improved,TransForce2 Arch Developer Appliances. Two styles of the ...
... 8 The following statement was,issued today by ... bad,decisions that is a major contributing factor to ... of healthcare, reducing access and,dramatically adding to healthcare ... a significant increase according to recent polls.,Access difficulty ...
Cached Medicine News:Health News:Hodgkin lymphoma -- new characteristics discovered 2Health News:Hodgkin lymphoma -- new characteristics discovered 3Health News:Oregon's Assisted Suicide Law May Overlook Depressed Patients 2Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 2Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 3Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 4Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 5Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 6Health News:deCODE Launches deCODE BreastCancer(TM), a Genetic Test to Screen for Risk of the Common Forms of Breast Cancer 7Health News:2009 Nominations Open for The Dr. Paul Janssen Award for Biomedical Research 2Health News:2009 Nominations Open for The Dr. Paul Janssen Award for Biomedical Research 3Health News:The Next Generation of Arch Expansion has Arrived 2Health News:HealthMadeEasy.com: Our Healthcare System Is Hemorrhaging 2Health News:HealthMadeEasy.com: Our Healthcare System Is Hemorrhaging 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: